Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. We are dedicated to capturing the scientific opportunities of our time. With our early roots in Sweden, we started as pioneers in haemophilia. Today we are an innovative leader within rare diseases with a global reach. Together we are bringing brilliant ideas to life. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.
Looking for a particular Sobi - Swedish Orphan Biovitrum AB (publ) employee's phone or email?
The Sobi - Swedish Orphan Biovitrum AB (publ) annual revenue was $2.3 billion in 2026.
Sayeh Khoogar is the CMO Manager of Sobi - Swedish Orphan Biovitrum AB (publ).
1,345 people are employed at Sobi - Swedish Orphan Biovitrum AB (publ).
Sobi - Swedish Orphan Biovitrum AB (publ) is based in Stockholm, Stockholm County.
The NAICS codes for Sobi - Swedish Orphan Biovitrum AB (publ) are [325, 32, 3254, 32541].
The SIC codes for Sobi - Swedish Orphan Biovitrum AB (publ) are [28, 283].